Skip to main content

Table 1 Characteristic of the study population

From: Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)

 

EBRT group

RBRT+HDRB group

No of patients

88

23

Median age (Range)

69(46–84)

69(50–78)

Tumor stage

  

   T1

20

4

   T2

59

15

   T3

9

4

Gleason score

  

   2–6

55

14

   7

21

7

   8–10

12

2

Pretreatment PSA (ng/ml)

Mean: 14.1

Mean: 12.3

 

Median: 8.7

Median: 8.9

 

Range: 1.7 – 161.8

Range: 0.8 – 51.9

   ≤ 10

46

14

   10–20

31

5

   ≥ 20

11

4

Radiotherapy dose

66–70 Gy/33–35 Fr

40 Gy+16.5 Gy Brachy

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us